BON Bon Natural Life Limited - Fundamental Analysis
BEARISH
Sign in to save
Save this symbol to a watchlist or track a position.
BON Stock | Fundamental Analysis & Investment Insights
NASDAQ
Basic Materials
Specialty Chemicals
Current Price
Live
$1.7
52W High
$73.75
52W Low
$1.14
At a glance
Key valuation, profitability, growth, and risk metrics.
AI Analysis
Powered by advanced machine learning algorithms
Confidence Score
85%
Analysis Accuracy
The company exhibits weak fundamental health with a Piotroski F-Score of 6/9, indicating borderline stability, and lacks an Altman Z-Score, raising concerns about financial distress risk. Despite trading at a steep discount to the Graham Number ($337.95 vs. current price of $1.70), the business shows deteriorating fundamentals, including a -21.90% YoY revenue decline and minimal profitability. Negative long-term price performance (-99.9% over 5 years) and absence of analyst coverage further signal investor abandonment. While balance sheet metrics appear healthy, the lack of growth, cash flow data, and earnings visibility undermines any value proposition.
Key Strengths
Low P/E ratio of 0.08 suggests extreme valuation discount relative to earnings
Strong current ratio of 2.44 indicates solid short-term liquidity
Low debt/equity ratio of 0.16 reflects conservative capital structure
Price/Sales of 0.80 is below sector average, suggesting potential undervaluation
Recent 6M price rebound of +23.2% may indicate speculative bottom formation
Key Risks
Revenue growth of -21.90% YoY shows severe top-line contraction
Missing Altman Z-Score prevents distress risk assessment; potential bankruptcy concern
Extremely low ROE of 1.19% and ROA of 2.13% indicate poor capital efficiency
Lack of EV, cash flow, and shares outstanding data suggests opacity or financial instability
5-year return of -99.9% reflects near-total equity destruction
AI Fair Value Estimate
Based on comprehensive analysis
$151.83
+8831.2% above current price
Performance Snowflake
Multi-dimensional AI analysis across 5 key categories
Stock Price & Analyst Targets
Real-time price movements and analyst price targets
Historical Performance Trends
Long-term financial metrics and growth patterns
Valuation Metrics
Key valuation ratios and pricing indicators
Profitability, Growth & Financial Health
Detailed profit margins, ROE, debt ratios, and liquidity metrics
Sector Comparison & Peer Analysis
Compare BON against industry averages and similar companies
Insider Trading & Analyst Ratings
Track insider transactions and Wall Street analyst recommendations
Past News Coverage
Recent headlines mentioning BON from our newsroom.
Newest → oldest
No matching news yet.